SAMDI Tech, a provider of label-free drug discovery solutions, has partnered with Enamine, a supplier of drug-like screening compounds, to expand the number of molecules in their small molecule compound libraries. Through the partnership, SAMDI Tech will be able to offer its clients access to more than a half-million screening compounds. “This partnership will provide us with the tools we need to continue to deliver increasingly comprehensive solutions to our clients,” said SAMDI ...